These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8608716)

  • 21. Influence of T-cell receptor genes on chronic experimental autoimmune encephalomyelitis.
    Jansson L; Olsson T; Holmdahl R
    Immunogenetics; 1993; 37(6):466-8. PubMed ID: 7679665
    [No Abstract]   [Full Text] [Related]  

  • 22. A novel protective model against experimental allergic encephalomyelitis in mice expressing a transgenic TCR-specific for myelin oligodendrocyte glycoprotein.
    Mendel I; Natarajan K; Ben-Nun A; Shevach EM
    J Neuroimmunol; 2004 Apr; 149(1-2):10-21. PubMed ID: 15020060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune tolerance to myelin proteins.
    Seamons A; Perchellet A; Goverman J
    Immunol Res; 2003; 28(3):201-21. PubMed ID: 14713715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The thymus plays a role in oral tolerance induction in experimental autoimmune encephalomyelitis.
    Song F; Gienapp IE; Shawler T; Guan Z; Whitacre CC
    Ann N Y Acad Sci; 2004 Dec; 1029():402-4. PubMed ID: 15681792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of central and peripheral T-cell tolerance: lessons from experimental models of multiple sclerosis.
    Anderton S; Burkhart C; Metzler B; Wraith D
    Immunol Rev; 1999 Jun; 169():123-37. PubMed ID: 10450513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of CTLA-4 in tolerance induction and T cell differentiation in experimental autoimmune encephalomyelitis: i.p. antigen administration.
    Ratts RB; Arredondo LR; Bittner P; Perrin PJ; Lovett-Racke AE; Racke MK
    Int Immunol; 1999 Dec; 11(12):1881-8. PubMed ID: 10590253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predominant expression of a T cell receptor V beta gene subfamily in autoimmune encephalomyelitis.
    Zamvil SS; Mitchell DJ; Lee NE; Moore AC; Waldor MK; Sakai K; Rothbard JB; McDevitt HO; Steinman L; Acha-Orbea H
    J Exp Med; 1988 May; 167(5):1586-96. PubMed ID: 2452856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MBP-induced experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Linker RA; Gold R
    J Immunol; 2004 Sep; 173(5):2896. PubMed ID: 15322142
    [No Abstract]   [Full Text] [Related]  

  • 29. Clonal modulation of experimental allergic encephalomyelitis by a monoclonal antibody directed to the T-cell receptor.
    Heber-Katz E; Owhashi M; Happ MP; Burns F; Shen N; Li X
    Ann N Y Acad Sci; 1988; 540():576-7. PubMed ID: 2462833
    [No Abstract]   [Full Text] [Related]  

  • 30. T cell recognition of distinct peptide:I-Au conformers in murine experimental autoimmune encephalomyelitis.
    Huang JC; Han M; Minguela A; Pastor S; Qadri A; Ward ES
    J Immunol; 2003 Sep; 171(5):2467-77. PubMed ID: 12928395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-cell activation and receptor downmodulation precede deletion induced by mucosally administered antigen.
    Benson JM; Campbell KA; Guan Z; Gienapp IE; Stuckman SS; Forsthuber T; Whitacre CC
    J Clin Invest; 2000 Oct; 106(8):1031-8. PubMed ID: 11032863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral tolerance to copolymer 1 in myelin basic protein (MBP) TCR transgenic mice: cross-reactivity with MBP-specific TCR and differential induction of anti-inflammatory cytokines.
    Maron R; Slavin AJ; Hoffmann E; Komagata Y; Weiner HL
    Int Immunol; 2002 Feb; 14(2):131-8. PubMed ID: 11809732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of CTLA-4 in tolerance induction and ttigen administration cell differentiation in experimental autoimmune encephalomyelitis: i. v. antigen administration.
    Ratts RB; Arredondo LR; Bittner P; Perrin PJ; Lovett-Racke AE; Racke MK
    Int Immunol; 1999 Dec; 11(12):1889-96. PubMed ID: 10590254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells.
    Kim YC; Zhang AH; Yoon J; Culp WE; Lees JR; Wucherpfennig KW; Scott DW
    J Autoimmun; 2018 Aug; 92():77-86. PubMed ID: 29857928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A human leucocyte antigen-DR1 transgene confers susceptibility to experimental allergic encephalomyelitis elicited by an epitope of myelin basic protein.
    Sireci G; Dieli F; Caccamo N; Barera A; Carta P; Di Sano C; Meraviglia S; Bonanno CT; Salerno A
    Scand J Immunol; 2003 Aug; 58(2):188-94. PubMed ID: 12869140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mechanisms involved in the regulation of immune response in experimental autoimmune encephalomyelitis in mice].
    Tutaj M; Szczepanik M
    Postepy Hig Med Dosw (Online); 2006; 60():571-83. PubMed ID: 17115007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myelin basic protein-specific T cell clones and experimental allergic encephalomyelitis.
    Lemire JM; Weigle WO
    Pathol Immunopathol Res; 1986; 5(3-5):248-52. PubMed ID: 2440016
    [No Abstract]   [Full Text] [Related]  

  • 38. TCR V gene usage in autoimmunity.
    Gold DP
    Curr Opin Immunol; 1994 Dec; 6(6):907-12. PubMed ID: 7536011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE).
    Kumar V; Stellrecht K; Sercarz E
    J Exp Med; 1996 Nov; 184(5):1609-17. PubMed ID: 8920851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptide-specific prevention of experimental allergic encephalomyelitis. Neonatal tolerance induced to the dominant T cell determinant of myelin basic protein.
    Clayton JP; Gammon GM; Ando DG; Kono DH; Hood L; Sercarz EE
    J Exp Med; 1989 May; 169(5):1681-91. PubMed ID: 2469764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.